MCL1 and cancer: Since BCL-2 and MCL-1 proteins may have overlapping anti-apoptotic functions with BCL-XL in cancer cells, we compared the impact of their mRNA expression levels, either alone or in combination with CDK1, CDK6 and WEE1, on the overall survival of TNBC patients.